APO Research

APO RESEARCH · REPORT

Nanopore Long-Reads Sequencing

Selected research

Market Analysis & Forecast

Global Nanopore Long-Reads Sequencing Market Analysis and Forecast 2026-2032

Market perspective

The global Nanopore Long-Reads Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nanopore Long-Reads Sequencing include Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Limited, Thermo Fisher, Roche, 10X Genomics, Eurofins Genomics, Stratos Genomics, Inc., MicrobesNG and NextOmics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nanopore Long-Reads Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nanopore Long-Reads Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanopore Long-Reads Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanopore Long-Reads Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanopore Long-Reads Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanopore Long-Reads Sequencing revenue, projected growth trends, production technology, application and end-user industry.

Nanopore Long-Reads Sequencing Segment by Company

Pacific Biosciences of California, Inc.

Oxford Nanopore Technologies Limited

Thermo Fisher

Roche

10X Genomics

Eurofins Genomics

Stratos Genomics, Inc.

MicrobesNG

NextOmics

New England Biolabs

Pacbio

Illumina

Stratos Genomics

Nanopore Long-Reads Sequencing Segment by Type

Pre-sequencing

Sequencing

Data Analysis

Nanopore Long-Reads Sequencing Segment by Application

Medical

Non-medical

Nanopore Long-Reads Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Long-Reads Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanopore Long-Reads Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Long-Reads Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nanopore Long-Reads Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nanopore Long-Reads Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanopore Long-Reads Sequencing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanopore Long-Reads Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pre-sequencing Major Player Table 3. Sequencing Major Player Table 4. Data Analysis Major Player Table 5. Global Nanopore Long-Reads Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Major Player Table 7. Non-medical Major Player Table 8. Nanopore Long-Reads Sequencing Industry Trends Table 9. Nanopore Long-Reads Sequencing Industry Drivers Table 10. Nanopore Long-Reads Sequencing Industry Opportunities and Challenges Table 11. Nanopore Long-Reads Sequencing Industry Restraints Table 12. Global Nanopore Long-Reads Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Nanopore Long-Reads Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Nanopore Long-Reads Sequencing Market Share by Region (2021-2026) Table 15. Global Nanopore Long-Reads Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Nanopore Long-Reads Sequencing Market Share by Region (2027-2032) Table 17. Global Nanopore Long-Reads Sequencing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Nanopore Long-Reads Sequencing Revenue Market Share by Players (2021-2026) Table 19. Global Nanopore Long-Reads Sequencing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Nanopore Long-Reads Sequencing Key Players Headquarters & Area Served Table 21. Global Nanopore Long-Reads Sequencing Players, Product Type & Application Table 22. Global Nanopore Long-Reads Sequencing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Nanopore Long-Reads Sequencing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Nanopore Long-Reads Sequencing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Nanopore Long-Reads Sequencing Revenue Market Share by Type (2021-2026) Table 29. Global Nanopore Long-Reads Sequencing Revenue Market Share by Type (2027-2032) Table 30. Global Nanopore Long-Reads Sequencing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2021-2026) Table 34. Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2027-2032) Table 35. Pacific Biosciences of California, Inc. Company Information Table 36. Pacific Biosciences of California, Inc. Business Overview Table 37. Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Product Portfolio Table 39. Pacific Biosciences of California, Inc. Recent Development Table 40. Oxford Nanopore Technologies Limited Company Information Table 41. Oxford Nanopore Technologies Limited Business Overview Table 42. Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Product Portfolio Table 44. Oxford Nanopore Technologies Limited Recent Development Table 45. Thermo Fisher Company Information Table 46. Thermo Fisher Business Overview Table 47. Thermo Fisher Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Nanopore Long-Reads Sequencing Product Portfolio Table 49. Thermo Fisher Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Roche Nanopore Long-Reads Sequencing Product Portfolio Table 54. Roche Recent Development Table 55. 10X Genomics Company Information Table 56. 10X Genomics Business Overview Table 57. 10X Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. 10X Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 59. 10X Genomics Recent Development Table 60. Eurofins Genomics Company Information Table 61. Eurofins Genomics Business Overview Table 62. Eurofins Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eurofins Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 64. Eurofins Genomics Recent Development Table 65. Stratos Genomics, Inc. Company Information Table 66. Stratos Genomics, Inc. Business Overview Table 67. Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Product Portfolio Table 69. Stratos Genomics, Inc. Recent Development Table 70. MicrobesNG Company Information Table 71. MicrobesNG Business Overview Table 72. MicrobesNG Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. MicrobesNG Nanopore Long-Reads Sequencing Product Portfolio Table 74. MicrobesNG Recent Development Table 75. NextOmics Company Information Table 76. NextOmics Business Overview Table 77. NextOmics Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. NextOmics Nanopore Long-Reads Sequencing Product Portfolio Table 79. NextOmics Recent Development Table 80. New England Biolabs Company Information Table 81. New England Biolabs Business Overview Table 82. New England Biolabs Nanopore Long-Reads Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. New England Biolabs Nanopore Long-Reads Sequencing Product Portfolio Table 84. New England Biolabs Recent Development Table 85. Pacbio Company Information Table 86. Pacbio Business Overview Table 87. Pacbio Nanopore Long-Reads Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Pacbio Nanopore Long-Reads Sequencing Product Portfolio Table 89. Pacbio Recent Development Table 90. Illumina Company Information Table 91. Illumina Business Overview Table 92. Illumina Nanopore Long-Reads Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Illumina Nanopore Long-Reads Sequencing Product Portfolio Table 94. Illumina Recent Development Table 95. Stratos Genomics Company Information Table 96. Stratos Genomics Business Overview Table 97. Stratos Genomics Nanopore Long-Reads Sequencing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Stratos Genomics Nanopore Long-Reads Sequencing Product Portfolio Table 99. Stratos Genomics Recent Development Table 100. North America Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Nanopore Long-Reads Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Nanopore Long-Reads Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Nanopore Long-Reads Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Nanopore Long-Reads Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 114. China Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 115. China Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 116. China Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 117. China Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Nanopore Long-Reads Sequencing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Nanopore Long-Reads Sequencing Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Nanopore Long-Reads Sequencing Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Nanopore Long-Reads Sequencing Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Nanopore Long-Reads Sequencing Image Figure 2. Global Nanopore Long-Reads Sequencing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanopore Long-Reads Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pre-sequencing Image Figure 5. Sequencing Image Figure 6. Data Analysis Image Figure 7. Global Nanopore Long-Reads Sequencing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nanopore Long-Reads Sequencing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Image Figure 10. Non-medical Image Figure 11. Global Nanopore Long-Reads Sequencing Market Size (US$ Million) & (2021-2032) Figure 12. Global Nanopore Long-Reads Sequencing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nanopore Long-Reads Sequencing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Nanopore Long-Reads Sequencing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Nanopore Long-Reads Sequencing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nanopore Long-Reads Sequencing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Nanopore Long-Reads Sequencing Revenue Market Share by Type (2021-2032) Figure 19. Global Nanopore Long-Reads Sequencing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2021-2032) Figure 22. North America Nanopore Long-Reads Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032) Figure 24. North America Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032) Figure 25. North America Nanopore Long-Reads Sequencing Revenue Share by Country (2021-2032) Figure 26. United States Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Nanopore Long-Reads Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032) Figure 31. Europe Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032) Figure 32. Europe Nanopore Long-Reads Sequencing Revenue Share by Country (2021-2032) Figure 33. Germany Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Nanopore Long-Reads Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032) Figure 43. China Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032) Figure 44. Asia Nanopore Long-Reads Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032) Figure 46. Asia Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032) Figure 47. Asia Nanopore Long-Reads Sequencing Revenue Share by Region (2021-2032) Figure 48. Japan Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Nanopore Long-Reads Sequencing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032) Figure 56. SAMEA Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032) Figure 57. SAMEA Nanopore Long-Reads Sequencing Revenue Share by Country (2021-2032) Figure 58. Brazil Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Nanopore Long-Reads Sequencing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-sequencing
  • Sequencing
  • Data Analysis
Applications
  • Medical
  • Non-medical
Companies covered
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Limited
  • Thermo Fisher
  • Roche
  • 10X Genomics
  • Eurofins Genomics
  • Stratos Genomics, Inc.
  • MicrobesNG
  • NextOmics
  • New England Biolabs
  • Pacbio
  • Illumina
  • Stratos Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nanopore Long-Reads Sequencing Market by Type
  3. 1.2.1 Global Nanopore Long-Reads Sequencing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pre-sequencing
  5. 1.2.3 Sequencing
  6. 1.2.4 Data Analysis
  7. 1.3 Nanopore Long-Reads Sequencing Market by Application
  8. 1.3.1 Global Nanopore Long-Reads Sequencing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical
  10. 1.3.3 Non-medical
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Nanopore Long-Reads Sequencing Market Dynamics
  1. 2.1 Nanopore Long-Reads Sequencing Industry Trends
  2. 2.2 Nanopore Long-Reads Sequencing Industry Drivers
  3. 2.3 Nanopore Long-Reads Sequencing Industry Opportunities and Challenges
  4. 2.4 Nanopore Long-Reads Sequencing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nanopore Long-Reads Sequencing Market Perspective (2021-2032)
  2. 3.2 Global Nanopore Long-Reads Sequencing Growth Trends by Region
  3. 3.2.1 Global Nanopore Long-Reads Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nanopore Long-Reads Sequencing Market Size by Region (2021-2026)
  5. 3.2.3 Global Nanopore Long-Reads Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nanopore Long-Reads Sequencing Revenue by Players
  2. 4.1.1 Global Nanopore Long-Reads Sequencing Revenue by Players (2021-2026)
  3. 4.1.2 Global Nanopore Long-Reads Sequencing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nanopore Long-Reads Sequencing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nanopore Long-Reads Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nanopore Long-Reads Sequencing Key Players Headquarters & Area Served
  7. 4.4 Global Nanopore Long-Reads Sequencing Players, Product Type & Application
  8. 4.5 Global Nanopore Long-Reads Sequencing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nanopore Long-Reads Sequencing Market CR5 and HHI
  11. 4.6.3 2025 Nanopore Long-Reads Sequencing Tier 1, Tier 2, and Tier 3
5 Nanopore Long-Reads Sequencing Market Size by Type
  1. 5.1 Global Nanopore Long-Reads Sequencing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 5.3 Global Nanopore Long-Reads Sequencing Revenue Market Share by Type (2021-2032)
6 Nanopore Long-Reads Sequencing Market Size by Application
  1. 6.1 Global Nanopore Long-Reads Sequencing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  3. 6.3 Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pacific Biosciences of California, Inc.
  2. 7.1.1 Pacific Biosciences of California, Inc. Company Information
  3. 7.1.2 Pacific Biosciences of California, Inc. Business Overview
  4. 7.1.3 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Product Portfolio
  6. 7.1.5 Pacific Biosciences of California, Inc. Recent Developments
  7. 7.2 Oxford Nanopore Technologies Limited
  8. 7.2.1 Oxford Nanopore Technologies Limited Company Information
  9. 7.2.2 Oxford Nanopore Technologies Limited Business Overview
  10. 7.2.3 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Product Portfolio
  12. 7.2.5 Oxford Nanopore Technologies Limited Recent Developments
  13. 7.3 Thermo Fisher
  14. 7.3.1 Thermo Fisher Company Information
  15. 7.3.2 Thermo Fisher Business Overview
  16. 7.3.3 Thermo Fisher Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Nanopore Long-Reads Sequencing Product Portfolio
  18. 7.3.5 Thermo Fisher Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche Nanopore Long-Reads Sequencing Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 10X Genomics
  26. 7.5.1 10X Genomics Company Information
  27. 7.5.2 10X Genomics Business Overview
  28. 7.5.3 10X Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 10X Genomics Nanopore Long-Reads Sequencing Product Portfolio
  30. 7.5.5 10X Genomics Recent Developments
  31. 7.6 Eurofins Genomics
  32. 7.6.1 Eurofins Genomics Company Information
  33. 7.6.2 Eurofins Genomics Business Overview
  34. 7.6.3 Eurofins Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eurofins Genomics Nanopore Long-Reads Sequencing Product Portfolio
  36. 7.6.5 Eurofins Genomics Recent Developments
  37. 7.7 Stratos Genomics, Inc.
  38. 7.7.1 Stratos Genomics, Inc. Company Information
  39. 7.7.2 Stratos Genomics, Inc. Business Overview
  40. 7.7.3 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Product Portfolio
  42. 7.7.5 Stratos Genomics, Inc. Recent Developments
  43. 7.8 MicrobesNG
  44. 7.8.1 MicrobesNG Company Information
  45. 7.8.2 MicrobesNG Business Overview
  46. 7.8.3 MicrobesNG Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MicrobesNG Nanopore Long-Reads Sequencing Product Portfolio
  48. 7.8.5 MicrobesNG Recent Developments
  49. 7.9 NextOmics
  50. 7.9.1 NextOmics Company Information
  51. 7.9.2 NextOmics Business Overview
  52. 7.9.3 NextOmics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NextOmics Nanopore Long-Reads Sequencing Product Portfolio
  54. 7.9.5 NextOmics Recent Developments
  55. 7.10 New England Biolabs
  56. 7.10.1 New England Biolabs Company Information
  57. 7.10.2 New England Biolabs Business Overview
  58. 7.10.3 New England Biolabs Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 New England Biolabs Nanopore Long-Reads Sequencing Product Portfolio
  60. 7.10.5 New England Biolabs Recent Developments
  61. 7.11 Pacbio
  62. 7.11.1 Pacbio Company Information
  63. 7.11.2 Pacbio Business Overview
  64. 7.11.3 Pacbio Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pacbio Nanopore Long-Reads Sequencing Product Portfolio
  66. 7.11.5 Pacbio Recent Developments
  67. 7.12 Illumina
  68. 7.12.1 Illumina Company Information
  69. 7.12.2 Illumina Business Overview
  70. 7.12.3 Illumina Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Illumina Nanopore Long-Reads Sequencing Product Portfolio
  72. 7.12.5 Illumina Recent Developments
  73. 7.13 Stratos Genomics
  74. 7.13.1 Stratos Genomics Company Information
  75. 7.13.2 Stratos Genomics Business Overview
  76. 7.13.3 Stratos Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Stratos Genomics Nanopore Long-Reads Sequencing Product Portfolio
  78. 7.13.5 Stratos Genomics Recent Developments
8 North America
  1. 8.1 North America Nanopore Long-Reads Sequencing Revenue (2021-2032)
  2. 8.2 North America Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 8.2.1 North America Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
  4. 8.2.2 North America Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
  5. 8.3 North America Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
  6. 8.4 North America Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  7. 8.4.1 North America Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
  8. 8.4.2 North America Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
  9. 8.5 North America Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
  10. 8.6 North America Nanopore Long-Reads Sequencing Revenue by Country
  11. 8.6.1 North America Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
  13. 8.6.3 North America Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nanopore Long-Reads Sequencing Revenue (2021-2032)
  2. 9.2 Europe Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
  5. 9.3 Europe Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
  9. 9.5 Europe Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nanopore Long-Reads Sequencing Revenue by Country
  11. 9.6.1 Europe Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nanopore Long-Reads Sequencing Revenue (2021-2032)
  2. 10.2 China Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 10.2.1 China Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
  4. 10.2.2 China Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
  5. 10.3 China Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
  6. 10.4 China Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  7. 10.4.1 China Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
  8. 10.4.2 China Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
  9. 10.5 China Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nanopore Long-Reads Sequencing Revenue (2021-2032)
  2. 11.2 Asia Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
  5. 11.3 Asia Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
  9. 11.5 Asia Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nanopore Long-Reads Sequencing Revenue by Country
  11. 11.6.1 Asia Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nanopore Long-Reads Sequencing Revenue (2021-2032)
  2. 12.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nanopore Long-Reads Sequencing Revenue by Country
  11. 12.6.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research